Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)

Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,626 · see citing works

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works

The mechanisms of action of PPARs

Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659 · see citing works

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ

Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164 · see citing works

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

Development and Validation of Real-Time Quantitative Reverse Transcriptase–Polymerase Chain Reaction for Monitoring Gene Expression in Cardiac Myocytesin Vitro

Winer, J., Jung, C. K. S., Shackel, I., & Williams, P. M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4085 · Cited by 1,388 · see citing works

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B. (1999) · Endocrine Reviews · doi:10.1210/er.20.5.649 · Cited by 1,251 · see citing works

PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173 · see citing works

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

Fu, J., Gaetani, S., Oveisi, F., Verme, J., Serrano, A., de Fonseca, F. D., Rosengarth, A., Luecke, H., Giacomo, B. D., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,113 · see citing works

The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882 · see citing works

Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D. J., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 854 · see citing works

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775 · see citing works

Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids

Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C., McMahon, G., Brown, M. A., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 709 · see citing works

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M., Patel, L., et al. (2002) · Biochemistry · doi:10.1021/bi0159581 · Cited by 566 · see citing works

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

Combs, T. P., Wagner, J. A., Berger, J. P., Doebber, T. W., Wang, W., Zhang, B. B., Tanen, M. R. L., Berg, A. H., O’Rahilly, S., Savage, D. B., et al. (2002) · Endocrinology · doi:10.1210/endo.143.3.8662 · Cited by 565 · see citing works

Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2

Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 406 · see citing works

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 389 · see citing works

Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)

Guzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404087200 · Cited by 328 · see citing works

Polyunsaturated Fatty Acids Including Docosahexaenoic and Arachidonic Acid Bind to the Retinoid X Receptor α Ligand-binding Domain

Lengqvist, J., Mata de Urquiza, A., Bergman, A.-C., Willson, T. M., Sjövall, J., Perlmann, T., & Griffiths, W. J. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400003-mcp200 · Cited by 323 · see citing works

The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK‐1

Maingret, F., Patel, A. J., Lazdunski, M., & Honoré, É. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.47 · Cited by 313 · see citing works

Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamide

Chemin, J., Monteil, A., Perez‐Reyes, E., Nargeot, J., & Lory, P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299 · see citing works

A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity

Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 273 · see citing works

Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ

Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 261 · see citing works

A Role for C/EBPβ in Regulating Peroxisome Proliferator-activated Receptor γ Activity during Adipogenesis in 3T3-L1 Preadipocytes

Hamm, J. K., Park, B. H., & Farmer, S. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100797200 · Cited by 260 · see citing works

The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase

Deutsch, D. G., Glaser, S. T., Howell, J. M., Kunz, J. S., Puffenbarger, R. A., Hillard, C. J., & Abumrad, N. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003161200 · Cited by 206 · see citing works

15-Lipoxygenase Metabolism of 2-Arachidonylglycerol

Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., BRASH, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 187 · see citing works

Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB

Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 186 · see citing works

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 167 · see citing works

Oxidative metabolism of anandamide

BURSTEIN, S. H., Rossetti, R. G., Yagen, B., & Zurier, R. B. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00053-8 · Cited by 145 · see citing works

Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., & Martin, B. R. (1999) · PubMed · Cited by 132 · see citing works

Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid

Liu, J., Li, H., Burstein, S. H., Zurier, R. B., & Chen, J. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.983 · Cited by 129 · see citing works

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPAR Agonists: A Potential Mechanism of Insulin Sensitization

Combs, T. P. (2002) · Endocrinology · doi:10.1210/en.143.3.998 · Cited by 126 · see citing works

Anandamide Inhibits Nuclear Factor-κB Activation through a Cannabinoid Receptor-Independent Pathway

Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G., & Muñoz, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.429 · Cited by 120 · see citing works

Cannabimimetic Fatty Acid Derivatives: The Anandamide Family and Other 'Endocannabinoids'

Melck, D. J., Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., & Martin, B. R. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401141630 · Cited by 119 · see citing works

Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528

Bouaboula, M., Dussossoy, D., & Casellas, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20397 · Cited by 107 · see citing works

Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts

Sarker, K. P., & Maruyama, I. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3055-2 · Cited by 104 · see citing works

Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells

Berdyshev, E. V., Schmid, P. C., Dong, Z., & Schmid, H. H. O. (2000) · Biochemical Journal · doi:10.1042/bj3460369 · Cited by 97 · see citing works

A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes

Rockwell, C. E., & Kaminski, N. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065524 · Cited by 86 · see citing works

Cannabinoid-receptor-independent cell signalling by N-acylethanolamines

Berdyshev, E. V., Schmid, P. C., Krebsbach, R. J., Hillard, C. J., Huang, C., Chen, N., Dong, Z., & Schmid, H. H. O. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600067 · Cited by 73 · see citing works

Endocannabinoids New Targets for Drug Development

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399365 · Cited by 68 · see citing works

Role of Peroxisome Proliferator-Activated Receptor g and Its Ligands in the Control of Immune Responses

Nencioni, A., Wesselborg, S., & Brossart, P. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i12.10 · Cited by 63 · see citing works

Lipid Droplet Formation in Human Myeloid NB4 Cells Stimulated by All Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor: Possible Involvement of Peroxisome Proliferator-Activated Receptor .GAMMA.

Inazawa, Y., Nakatsu, M., Yasugi, E., Saeki, K., & Yuo, A. (2003) · Cell Structure and Function · doi:10.1247/csf.28.487 · Cited by 20 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,610 · see citing works

An Introduction to the Endogenous Cannabinoid System

Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234 · see citing works

The endocannabinoid system links gut microbiota to adipogenesis

Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691 · see citing works

The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders

Silvestri, C., & Marzo, V. D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 546 · see citing works

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors

O’Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 509 · see citing works

An update on PPAR activation by cannabinoids

O’Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 469 · see citing works

Endocannabinoid signalling and the deteriorating brain

Marzo, V. D., Stella, N., & Zimmer, A. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3876 · Cited by 381 · see citing works

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men

Côté, M., Matias, I., Lemieux, I., Petrosino, S., Alméras, N., Després, J., & Marzo, V. D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803539 · Cited by 382 · see citing works

Endocannabinoids and the control of energy balance

Matias, I., & Marzo, V. D. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.11.006 · Cited by 367 · see citing works

Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression

Park, J., Euhus, D., & Scherer, P. E. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0030 · Cited by 349 · see citing works

Leptin controls adipose tissue lipogenesis via central, STAT3–independent mechanisms

Buettner, C., Muse, E. D., Cheng, A. M., Chen, L., Scherer, T., Pocai, A., Su, K., Cheng, B., Li, X., Harvey-White, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1775 · Cited by 342 · see citing works

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works

Endocannabinoids and Their Pharmacological Actions

Pertwee, R. G. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_1 · Cited by 302 · see citing works

Why do cannabinoid receptors have more than one endogenous ligand?

Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290 · see citing works

Cannabinoids and Cytochrome P450 Interactions

Zendulka, O., Dovrtělová, G., Nosková, K., Turjap, M., Šulcová, A., Hanuš, L., & Juřica, J. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666151210142051 · Cited by 297 · see citing works

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors

Costa, B., Comelli, F., Bettoni, I., Colleoni, M., & Giagnoni, G. (2008) · Pain · doi:10.1016/j.pain.2008.06.003 · Cited by 286 · see citing works

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation

Galve‐Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 280 · see citing works

An introduction to the endocannabinoid system: from the early to the latest concepts

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 252 · see citing works

Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease

O’Sullivan, S. E., & Kendall, D. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 247 · see citing works

Cannabinoid activation of PPARα; a novel neuroprotective mechanism

Sun, Y., Alexander, S. P. H., Garle, M. J., Gibson, C. L., Hewitt, K. N., Murphy, S. P., Kendall, D. A., & Bennett, A. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707478 · Cited by 229 · see citing works

Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx073 · Cited by 226 · see citing works

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224 · see citing works

Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9177-z · Cited by 216 · see citing works

The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms

Pagano, C., Pilon, C., Calcagno, A., Urbanet, R., Rossato, M., Milan, G., Bianchi, K., Rizzuto, R., Bernante, P., Federspil, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0768 · Cited by 209 · see citing works

Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High‐fat Diet

Starowicz, K., Cristino, L., Matias, I., Capasso, R., Racioppi, A., Izzo, A. A., & Marzo, V. D. (2008) · Obesity · doi:10.1038/oby.2007.106 · Cited by 194 · see citing works

Time-dependent vascular actions of cannabidiol in the rat aorta

O’Sullivan, S. E., Sun, Y., Bennett, A. J., Randall, M. D., & Kendall, D. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.010 · Cited by 179 · see citing works

Intracellular trafficking of anandamide: new concepts for signaling

Maccarrone, M., Dainese, E., & Oddi, S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.008 · Cited by 169 · see citing works

Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling

Manca, C., Boubertakh, B., Leblanc, N., Deschênes, T., Lacroix, S., Martin, C., Houde, A., Veilleux, A., Flamand, N., Muccioli, G. G., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000424 · Cited by 152 · see citing works

Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver

Tedesco, L., Valerio, A., Dossena, M., Cardile, A., Ragni, M., Pagano, C., Pagotto, U., Carruba, M. O., Vettor, R., & Nisoli, E. (2010) · Diabetes · doi:10.2337/db09-1881 · Cited by 149 · see citing works

Endogenous cannabinoids revisited: A biochemistry perspective

Fonseca, B. M., Costa, M. A., Almada, M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.002 · Cited by 147 · see citing works

Chlorinated Polyfluorinated Ether Sulfonates Exhibit Higher Activity toward Peroxisome Proliferator-Activated Receptors Signaling Pathways than Perfluorooctanesulfonate

Li, C.-H., Ren, X., Ruan, T., Cao, L.-Y., Yan, X., Guo, L., & Jiang, G. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b06327 · Cited by 144 · see citing works

From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets

Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 142 · see citing works

The Endocannabinoid Signaling System in the CNS

Hillard, C. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 135 · see citing works

Advances in the Physiology of GPR55 in the Central Nervous System

Marichal‐Cancino, B. A., Fajardo-Valdez, A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160729155441 · Cited by 133 · see citing works

The complications of promiscuity: endocannabinoid action and metabolism

Alexander, S. P. H., & Kendall, D. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707456 · Cited by 133 · see citing works

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation

Iannotti, F. A., & Vitale, R. M. (2021) · Cells · doi:10.3390/cells10030586 · Cited by 132 · see citing works

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake

Gasperi, V., Fezza, F., Pasquariello, N., Bari, M., Oddi, S., Finazzi‐Agrò, A., & Maccarrone, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6445-4 · Cited by 131 · see citing works

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

Patricio, F., Morales-Andrade, A. A., Patricio-Martínez, A., & Limón, I. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595635 · Cited by 129 · see citing works

The thrifty lipids: endocannabinoids and the neural control of energy conservation

DiPatrizio, N. V., & Piomelli, D. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.006 · Cited by 128 · see citing works

The Endocannabinoid System and Energy Metabolism

Bellocchio, L., Cervino, C., Pasquali, R., & Pagotto, U. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01728.x · Cited by 127 · see citing works

The Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals

Ringseis, R., Geßner, D. K., & Eder, K. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083852 · Cited by 127 · see citing works

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors

van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 129 · see citing works

The Endocannabinoid System and Its Relevance for Nutrition

Maccarrone, M., Gasperi, V., Catani, M. V., Diep, T. A., Dainese, E., Hansen, H. S., & Avigliano, L. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104701 · Cited by 122 · see citing works

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 121 · see citing works

The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders

del Río, C., Millán, E., García, V., Appendino, G., DeMesa, J., & Muñóz, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.022 · Cited by 119 · see citing works

Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.014 · Cited by 116 · see citing works

Omega‐3 Fatty Acids and PPARγ in Cancer

Edwards, I. J., & O’Flaherty, J. T. (2008) · PPAR Research · doi:10.1155/2008/358052 · Cited by 116 · see citing works

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

Marzo, V. D., Piscitelli, F., & Mechoulam, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_4 · Cited by 114 · see citing works

What we know and do not know about the cannabinoid receptor 2 (CB2)

Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M., & Dittel, B. N. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.002 · Cited by 112 · see citing works

Physical activity and the endocannabinoid system: an overview

Tantimonaco, M., Ceci, R., Sabatini, S., Catani, M. V., Rossi, A., Gasperi, V., & Maccarrone, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1575-6 · Cited by 112 · see citing works

Chapter 15 Anandamide and the Vanilloid Receptor (TRPV1)

Tóth, A., Blumberg, P. M., & Boczán, J. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81015-7 · Cited by 109 · see citing works

Cannabinoids: A New Group of Agonists of PPARs

Sun, Y., & Bennett, A. (2007) · PPAR Research · doi:10.1155/2007/23513 · Cited by 109 · see citing works

Cannabinoids and PPARα signalling

Sun, Y., Alexander, S. P. H., Kendall, D. A., & Bennett, A. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341095 · Cited by 109 · see citing works

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future

Simon, V., & Cota, D. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1044 · Cited by 107 · see citing works

Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues

Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2018) · Antioxidants · doi:10.3390/antiox7070093 · Cited by 108 · see citing works

Brain activity of anandamide: a rewarding bliss?

Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 105 · see citing works

Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells

Matias, I., Gonthier, M., Petrosino, S., Docimo, L., Capasso, R., Hoareau, L., Monteleone, P., Roche, R., Izzo, A. A., & Marzo, V. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707424 · Cited by 104 · see citing works

Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?

Bays, H. E., Blonde, L., & Rosenson, R. S. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.871 · Cited by 102 · see citing works

New insights on the role of the endocannabinoid system in the regulation of energy balance

Gatta‐Cherifi, B., & Cota, D. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.179 · Cited by 100 · see citing works

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

Correa, F., Docagne, F., Mestre, L., Clemente, D., Hernangómez, M., Loría, F., & Guaza, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.014 · Cited by 98 · see citing works

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

Loría, F., Petrosino, S., Hernangómez, M., Mestre, L., Spagnolo, A., Correa, F., Marzo, V. D., Docagne, F., & Guaza, C. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.020 · Cited by 96 · see citing works

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55

Alba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 94 · see citing works

Signal Transduction via Cannabinoid Receptors

Dalton, G. D., Bass, C. E., Horn, C. V., & Howlett, A. C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824615 · Cited by 94 · see citing works

Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action

Pereira, M. D. S., da-Silva, C. A., Guimarães, F. S., & Bel, E. A. D. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.013 · Cited by 95 · see citing works

Cannabinoid system in the skin – a possible target for future therapies in dermatology

Kupczyk, P., Reich, A., & Szepietowski, J. C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00923.x · Cited by 93 · see citing works

CB1 receptor antagonism: biological basis for metabolic effects

Marzo, V. D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.001 · Cited by 90 · see citing works

The role of the endocannabinoid system in lipogenesis and fatty acid metabolism

Vettor, R., & Pagano, C. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.002 · Cited by 88 · see citing works

Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues

de Azúa, I. R., & Lutz, B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2994-6 · Cited by 88 · see citing works

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients

Annuzzi, G., Piscitelli, F., Marino, L. D., Patti, L., Giacco, R., Costabile, G., Bozzetto, L., Riccardi, G., Verde, R., Petrosino, S., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-43 · Cited by 85 · see citing works

Endocannabinoids in the gastrointestinal tract

Lee, Y., Jo, J., Chung, H. Y., Pothoulakis, C., & Im, E. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00294.2015 · Cited by 82 · see citing works

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis

Bazwinsky‐Wutschke, I., Zipprich, A., & Dehghani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102516 · Cited by 82 · see citing works

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR‐α, PPAR‐γ and TRPV1, but not CB1 or CB2 receptors

Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 78 · see citing works

Endocannabinoids: Effectors of glucocorticoid signaling

Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 78 · see citing works

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol

Spoto, B., Fezza, F., Parlongo, G., Battista, N., Sgro, E., Gasperi, V., Zoccali, C., & Maccarrone, M. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.019 · Cited by 75 · see citing works

Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

Depommier, C., Vitale, R. M., Iannotti, F. A., Silvestri, C., Flamand, N., Druart, C., Everard, A., Pelicaen, R., Maiter, D. M., Thissen, J., et al. (2021) · Cells · doi:10.3390/cells10010185 · Cited by 73 · see citing works

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy

Ramer, R., Schwarz, R., & Hinz, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00430 · Cited by 73 · see citing works

Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation

Karaliota, S., Siafaka‐Kapadai, A., Gontinou, C., Psarra, K., & Mavri‐Vavayanni, M. (2009) · Obesity · doi:10.1038/oby.2009.177 · Cited by 71 · see citing works

PPARs and pain

Okine, B. N., Gaspar, J. C., & Finn, D. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14339 · Cited by 71 · see citing works

Adipocyte ATP-Binding Cassette G1 Promotes Triglyceride Storage, Fat Mass Growth, and Human Obesity

Frisdal, É., Lay, S. L., Hooton, H., Poupel, L., Olivier, M., Alili, R., Plengpanich, W., Villard, E. F., Gilibert, S., Lhomme, M., et al. (2014) · Diabetes · doi:10.2337/db14-0245 · Cited by 70 · see citing works

The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity

Heyman, E., Gamelin, F.-X., Aucouturier, J., & Marzo, V. D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01026.x · Cited by 69 · see citing works

Antagonism of peroxisome proliferator-activated receptor γ prevents high-fat diet-induced obesity in vivo

Nakano, R., Kurosaki, E., Yoshida, S., Yokono, M., Shimaya, A., Maruyama, T., & Shibasaki, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.023 · Cited by 69 · see citing works

Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion

Kunimasa, K., Kuranuki, S., Matsuura, N., Iwasaki, N., Ikeda, M., Ito, A., Sashida, Y., Mimaki, Y., Yano, M., Sato, M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.002 · Cited by 69 · see citing works

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: Involvement of the transcription factor PPARγ

Giuliano, M., Pellerito, O., Portanova, P., Calvaruso, G., Santulli, A., BLASIO, A. D., Vento, R., & Tesoriere, G. (2008) · Biochimie · doi:10.1016/j.biochi.2008.11.003 · Cited by 68 · see citing works

Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin

Holt, S., Paylor, B., Boldrup, L., Alajakku, K., Vandevoorde, S., Sundström, A. E., Cocco, M. T., Onnis, V., & Fowler, C. J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.051 · Cited by 67 · see citing works

Pioglitazone induces apoptosis of macrophages in human adipose tissue

Bodles, A. M., Varma, V., Yao‐Borengasser, A., Phanavanh, B., Peterson, C. A., McGehee, R. E., Rasouli, N., Wabitsch, M., & Kern, P. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600235-jlr200 · Cited by 67 · see citing works

Cannabinoid Type 1 Receptor: Another Arrow in the Adipocytes’ Bow

Bellocchio, L., Cervino, C., Vicennati, V., Pasquali, R., & Pagotto, U. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01682.x · Cited by 66 · see citing works

Latest advances in the discovery of fatty acid amide hydrolase inhibitors

Bisogno, T., & Maccarrone, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.780021 · Cited by 65 · see citing works

Ajulemic Acid, a Synthetic Nonpsychoactive Cannabinoid Acid, Bound to the Ligand Binding Domain of the Human Peroxisome Proliferator-activated Receptor γ

Ambrosio, A. L. B., Dias, S. M. G., Polikarpov, I., Zurier, R. B., BURSTEIN, S. H., & Garratt, R. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702538200 · Cited by 64 · see citing works

Up- and down-regulation of adiponectin expression and multimerization: Mechanisms and therapeutic implication

Liu, M., & Liu, F. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.008 · Cited by 63 · see citing works

The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2

Fulmer, M. L., & Thewke, D. P. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180206161457 · Cited by 63 · see citing works

Butylated hydroxyanisole isomers induce distinct adipogenesis in 3T3-L1 cells

Sun, Z., Yang, X., Liu, Q. S., Li, C., Zhou, Q., Fiedler, H., Liao, C., Zhang, J., & Jiang, G. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.120794 · Cited by 63 · see citing works

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats

Martinez, A. A., Morgese, M. G., Pisanu, A., Macheda, T., Paquette, M. A., Seillier, A., Cassano, T., Carta, A. R., & Giuffrida, A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.024 · Cited by 61 · see citing works

Syzygium aqueum leaf extract and its bioactive compounds enhances pre-adipocyte differentiation and 2-NBDG uptake in 3T3-L1 cells

Manaharan, T., Cheng, M., & Palanisamy, U. D. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.08.056 · Cited by 61 · see citing works

Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players

Lambert, D. M., & Muccioli, G. G. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f00061 · Cited by 61 · see citing works

Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation‐induced cognitive damage

Fishbein, M., Gafni, M., & Sarne, Y. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23452 · Cited by 59 · see citing works

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals

Murdolo, G., Kempf, K., Hammarstedt, A., Herder, C., Smith, U., & Jansson, P. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347440 · Cited by 58 · see citing works

Is fat taste ready for primetime?

DiPatrizio, N. V. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.03.002 · Cited by 58 · see citing works

Lipids as targets for novel anti-inflammatory therapies

Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 57 · see citing works

Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice

Schleicher, E. M., Ott, F. W., Müller, M., Silcher, B., Sichler, M. E., Löw, M. J., Wagner, J. M., & Bouter, Y. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00094 · Cited by 57 · see citing works

Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation

Karaliota, S., Siafaka‐Kapadai, A., Gontinou, C., Psarra, K., & Mavri‐Vavayanni, M. (2009) · Obesity · doi:10.1038/oby.2009.177 · Cited by 71 · see citing works

Regulated Production of a Peroxisome Proliferator-activated Receptor-γ Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes

Tzameli, I., Fang, H., Ollero, M., Shi, H., Hamm, J. K., Kievit, P., Hollenberg, A. N., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405346200 · Cited by 178 · see citing works

Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression Is Dependent on cAMP Signaling*

Hansen, J., Zhang, H., Rasmussen, T. H., Petersen, R., Flindt, E., & Kristiansen, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005567200 · Cited by 187 · see citing works

Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs

Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110 · see citing works

PPARγ and the control of adipogenesis

Spiegelman, B. M., Hu, E., Kim, J. B., & Brun, R. P. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81500-3 · Cited by 137 · see citing works